Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume $2.77 -0.18 (-6.10%) Closing price 03/5/2025 03:59 PM EasternExtended Trading$2.78 +0.02 (+0.54%) As of 03/5/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Aptevo Therapeutics Short Interest DataAptevo Therapeutics (APVO) has a short interest of 23,500 shares, representing 1.61% of the float (the number of shares available for trading by the public). This marks a -46.22% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 143,709 shares to cover all short positions.Current Short Interest23,500 sharesPrevious Short Interest43,700 sharesChange Vs. Previous Month-46.22%Dollar Volume Sold Short$78,490.00Short Interest Ratio0.1 Days to CoverLast Record DateFebruary 15, 2025Outstanding Shares1,458,000 sharesFloat Size1,460,000 sharesShort Percent of Float1.61%Today's Trading Volume27,109 sharesAverage Trading Volume143,709 sharesToday's Volume Vs. Average19% Short Selling Aptevo Therapeutics? Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPVO Short Interest Over TimeAPVO Days to Cover Over TimeAPVO Percentage of Float Shorted Over Time Aptevo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/202523,500 shares $78,490.00 -46.2%1.6%0.1 $3.34 1/31/202543,700 shares $191,406.00 +64.9%3.0%0.2 $4.38 1/15/202526,500 shares $120,575.00 +39.5%1.8%0.1 $4.55 12/31/202419,000 shares $81,890.00 -92.1%1.3%0.1 $4.31 12/15/2024241,700 shares $988,553.00 +536.1%16.6%0.8 $4.09 11/30/202438,000 shares $14.57 million -94.8%7.6%0.2 $383.32 11/15/2024734,600 shares $155,000.60 -38.8%N/A0.1 $0.21 10/31/20241,200,000 shares $323,880.00 +675.7%N/A0.2 $0.27 10/15/2024154,700 shares $22,416.03 +164.9%N/A0 $0.14 9/30/202458,400 shares $10,500.32 +349.2%N/A0 $0.18 Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/202413,000 shares $4,613.70 -78.8%N/A0 $0.35 8/31/202461,400 shares $22,104.00 -80.2%N/A0 $0.36 8/15/2024310,700 shares $135,154.50 -54.8%N/A0.1 $0.44 7/31/2024687,500 shares $277,268.75 +2.9%N/A0.1 $0.40 7/15/2024668,300 shares $203,965.16 +91.7%N/A0.1 $0.31 6/30/2024348,700 shares $106,702.20 +1,552.6%N/A0.4 $0.31 6/15/202421,100 shares $16,198.47 -55.8%0.5%0 $0.77 5/31/202447,700 shares $33,991.02 -11.7%1.2%0.1 $0.71 5/15/202454,000 shares $43,632.00 -79.9%1.3%0.1 $0.81 4/30/2024268,200 shares $190,609.74 +84.2%16.8%0.3 $0.71 4/15/2024145,600 shares $114,004.80 +324.5%9.1%0.6 $0.78 3/31/202434,300 shares $160,867.00 +18.7%5.1%0.3 $4.69 3/15/202428,900 shares $156,638.00 +725.7%5.5%0.3 $5.42 2/29/20243,500 shares $26,180.00 -82.1%N/A0 $7.48 2/15/202419,600 shares $3,077.20 +17.4%N/A0.1 $0.16 1/31/202416,700 shares $2,715.42 -78.8%N/A0 $0.16 1/15/202478,900 shares $12,545.10 -61.3%N/A0.2 $0.16 12/31/2023203,900 shares $36,905.90 +253.4%N/A0.3 $0.18 12/15/202357,700 shares $9,924.40 -46.0%N/A0.1 $0.17 11/30/2023106,800 shares $19,971.60 +297.0%N/A0.2 $0.19 11/15/202326,900 shares $4,976.50 -74.2%N/A0.1 $0.19 10/31/2023104,300 shares $29,485.61 -19.3%N/A0.2 $0.28 10/15/2023129,200 shares $41,344.00 +7.4%N/A0.3 $0.32 9/30/2023120,300 shares $39,699.00 +161.5%N/A0.4 $0.33 9/15/202346,000 shares $18,446.00 -46.6%N/A0.1 $0.40 8/31/202386,200 shares $37,928.00 +176.3%N/A0.3 $0.44 8/15/202331,200 shares $11,544.00 -97.8%N/A0.1 $0.37 7/31/20231,390,000 shares $1.45 million +3,837.7%N/A5.6 $1.04 7/15/202335,300 shares $52,950.00 +13.1%N/A0.2 $1.50 6/30/202331,200 shares $45,552.00 +51.5%N/A0.6 $1.46Elon’s “New Gold” (Ad)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.I reveal all of the details here. 6/15/202320,600 shares $32,960.00 -59.7%N/A0.4 $1.60 5/31/202351,100 shares $79,716.00 -28.0%N/A1 $1.56 5/15/202371,000 shares $117,150.00 -47.6%N/A1.3 $1.65 4/30/2023135,500 shares $260,160.00 +47.8%N/A2.4 $1.92 4/15/202391,700 shares $174,230.00 -35.1%N/A1.6 $1.90 3/31/2023141,200 shares $287,342.00 +34.2%N/A2 $2.04 3/15/2023105,200 shares $190,412.00 -30.1%N/A1.2 $1.81 2/28/2023150,400 shares $318,848.00 +118.6%N/A0.2 $2.12 2/15/202368,800 shares $141,040.00 -49.1%N/A0.1 $2.05 1/31/2023135,100 shares $310,730.00 -27.3%N/A0.2 $2.30 1/15/2023185,800 shares $418,050.00 -32.3%N/A0.2 $2.25 12/30/2022274,500 shares $636,840.00 -38.8%N/A0.4 $2.32 12/15/2022448,700 shares $1.01 million +764.6%N/A0.6 $2.25 11/30/202251,900 shares $161,928.00 -2.8%N/A1.5 $3.12 11/15/202253,400 shares $178,890.00 -12.3%N/A1.5 $3.35 10/31/202260,900 shares $183,918.00 +6.8%N/A1.3 $3.02 10/15/202257,000 shares $161,310.00 +8.6%N/A0.9 $2.83 9/30/202252,500 shares $159,600.00 +23.8%N/A0.9 $3.04 9/15/202242,400 shares $158,576.00 +3.9%N/A0.7 $3.74 8/31/202240,800 shares $144,432.00 -4.5%N/A0.4 $3.54 8/15/202242,700 shares $195,993.00 -48.9%N/A0.5 $4.59 7/31/202283,500 shares $328,990.00 -9.3%N/A1 $3.94 7/15/202292,100 shares $361,032.00 -30.2%N/A1.3 $3.92 6/30/2022132,000 shares $472,560.00 -24.8%N/A1.4 $3.58 6/15/2022175,600 shares $579,480.00 +20.9%N/A0.8 $3.30 5/31/2022145,200 shares $665,016.00 +1.0%N/A0.7 $4.58 5/15/2022143,700 shares $661,020.00 -13.4%N/A0.7 $4.60 4/30/2022165,900 shares $706,734.00 -12.2%N/A0.7 $4.26 4/15/2022188,900 shares $899,164.00 -6.3%N/A0.7 $4.76 3/31/2022201,600 shares $1.18 million +39.5%N/A0.8 $5.87 3/15/2022144,500 shares $647,360.00 +1.4%N/A1 $4.48 2/28/2022142,500 shares $820,800.00 -19.4%N/A0.6 $5.76 2/15/2022176,800 shares $1.11 million +247.4%N/A0.1 $6.29 1/31/202250,900 shares $297,256.00 -65.8%N/A0 $5.84 1/15/2022148,600 shares $1.07 million -35.3%N/A0 $7.22 12/31/2021229,500 shares $1.81 million -25.8%N/A0.1 $7.87 12/15/2021309,400 shares $2.44 million -72.4%N/A0.1 $7.90 11/30/20211,120,000 shares $11.16 million +1,182.9%N/A0.3 $9.96 11/15/202187,300 shares $848,556.00 +4.9%N/A0 $9.72 10/29/202183,200 shares $1.27 million +32.3%N/A1.6 $15.24 10/15/202162,900 shares $942,871.00 +4.7%N/A1.4 $14.99 9/30/202160,100 shares $927,944.00 -6.1%N/A1.2 $15.44 9/15/202164,000 shares $1.10 million -13.9%N/A1.2 $17.14 8/31/202174,300 shares $1.33 million -20.8%N/A1 $17.95 8/13/202193,800 shares $1.59 million -1.7%N/A1.2 $17.00 7/30/202195,400 shares $1.79 million -9.2%2.3%1.3 $18.77 7/15/2021105,100 shares $1.87 million -5.0%2.5%1.4 $17.75 6/30/2021110,600 shares $2.48 million +5.2%2.7%1.5 $22.43 6/15/2021105,100 shares $3.15 million -10.0%2.5%1.6 $30.00 5/28/2021116,800 shares $3.05 million +15.3%2.8%2.5 $26.12Your Wealth is Under Attack (Ad)Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold.Click here now to see how to stop them in their tracks! 5/14/2021101,300 shares $2.22 million -24.7%2.4%2.5 $21.93 4/30/2021134,600 shares $3.68 million +1.4%3.2%2.9 $27.34 4/15/2021132,800 shares $3.40 million -9.8%3.3%2.5 $25.57 3/31/2021147,300 shares $4.15 million -19.8%3.6%2.3 $28.20 3/15/2021183,600 shares $6.60 million -8.4%4.6%2.6 $35.97 2/26/2021200,500 shares $6.34 million +21.0%5.0%2.6 $31.62 2/12/2021165,700 shares $6.09 million +19.1%4.1%1.7 $36.76 1/29/2021139,100 shares $4.84 million +11.0%3.5%0.2 $34.83 1/15/2021125,300 shares $4.24 million -18.1%3.1%0.1 $33.82 12/31/2020153,000 shares $5.68 million -7.7%3.8%0.1 $37.11 12/15/2020165,800 shares $6.90 million -40.1%4.2%0.1 $41.61 11/30/2020276,700 shares $12.28 million -71.0%7.5%0.2 $44.39 11/15/2020955,400 shares $42.97 million +999.4%25.9%0.6 $44.98 10/30/202086,900 shares $572,671.00 +2.4%3.0%0.1 $6.59 10/15/202084,900 shares $594,300.00 -15.1%3.0%1.6 $7.00 9/30/2020100,000 shares $760,000.00 +33.7%3.5%1.2 $7.60 9/15/202074,800 shares $596,156.00 +9.2%2.6%0.1 $7.97 8/31/202068,500 shares $537,040.00 -20.3%2.4%0.1 $7.84 8/14/202085,900 shares $684,623.00 +39.7%3.0%0.1 $7.97 7/31/202061,500 shares $516,600.00 +27.6%2.1%0.1 $8.40 7/15/202048,200 shares $352,342.00 -75.1%1.7%0.1 $7.31 6/30/2020193,600 shares $1.62 million +147.6%6.7%0.3 $8.35 6/15/202078,200 shares $420,716.00 -0.4%2.7%0.8 $5.38 5/29/202078,500 shares $466,290.00 -3.8%2.7%0.6 $5.94 5/15/202081,600 shares $446,352.00 +54.0%2.8%0.6 $5.47 4/30/202053,000 shares $265,000.00 -8.5%1.8%0.4 $5.00 4/15/202057,900 shares $242,022.00 +2.1%2.0%0.7 $4.18 3/31/202056,700 shares $242,676.00 -93.8%2.0%0.7 $4.28 3/13/2020918,900 shares $3.53 million -44.3%2.3%0.3 $3.84 APVO Short Interest - Frequently Asked Questions What is Aptevo Therapeutics' current short interest? Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 15th, traders have sold 23,500 shares of APVO short. 1.61% of Aptevo Therapeutics' shares are currently sold short. Learn More on Aptevo Therapeutics' current short interest. Which institutional investors are shorting Aptevo Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptevo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aptevo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.61% of Aptevo Therapeutics' floating shares are currently sold short. Is Aptevo Therapeutics' short interest increasing or decreasing? Aptevo Therapeutics saw a drop in short interest during the month of February. As of February 15th, there was short interest totaling 23,500 shares, a drop of 46.2% from the previous total of 43,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aptevo Therapeutics' float size? Aptevo Therapeutics currently has issued a total of 1,458,000 shares. Some of Aptevo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptevo Therapeutics currently has a public float of 1,460,000 shares. How does Aptevo Therapeutics' short interest compare to its competitors? 1.61% of Aptevo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aptevo Therapeutics: Cocrystal Pharma, Inc. (0.21%), Senti Biosciences, Inc. (2.21%), Carisma Therapeutics, Inc. (2.85%), Leap Therapeutics, Inc. (7.46%), BioAtla, Inc. (8.95%), GlycoMimetics, Inc. (3.74%), MEI Pharma, Inc. (0.06%), Spruce Biosciences, Inc. (1.19%), Marker Therapeutics, Inc. (2.11%), MIRA Pharmaceuticals, Inc. (6.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks. What does it mean to sell short Aptevo Therapeutics stock? Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. APVO shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aptevo Therapeutics? A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further. How often is Aptevo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is February, 15 2025. More Short Interest Resources from MarketBeat Related Companies COCP Short Interest Data SNTI Short Interest Data CARM Short Interest Data LPTX Short Interest Data BCAB Short Interest Data GLYC Short Interest Data MEIP Short Interest Data SPRB Short Interest Data MRKR Short Interest Data MIRA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APVO) was last updated on 3/6/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrillion-Dollar Crypto PlayAI is Creating Fortunes… (but not where you think!) Bryce Paul and the team at Crypto101 just released a br...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APVO Stock Alerts